• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    OncoMed Pharmaceuticals, Inc. (OMED)

    -NasdaqGS
    11.94 Down 0.83(6.50%) 4:00PM EDT
    |After Hours : 11.93 Down 0.01 (0.05%) 5:19PM EDT - Nasdaq Real Time Price
    Prev Close:12.77
    Open:12.00
    Bid:11.93 x 1500
    Ask:20.00 x 100
    1y Target Est:18.00
    Beta:2.06729
    Earnings Date:Aug 8 - Aug 12 (Est.)
    Day's Range:11.72 - 12.21
    52wk Range:8.42 - 23.98
    Volume:335,130
    Avg Vol (3m):174,011
    Market Cap:361.76M
    P/E (ttm):N/A
    EPS (ttm):-3.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OMED

    Comparison

    Symbol% ChgMkt Cap
    OMEDDown 6.50%361.76M
    STMLDown 1.55%133.12M
    VSTMDown 2.24%48.46M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):17.15
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-3.29
    Quarterly EPS Est (Jun-16) :-0.81
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OncoMed Pharmaceuticals, Inc., a clinical development-stage biopharmaceutical company, discovers and develops novel anti-cancer stem cell (CSC) and immuno-oncology therapeutics. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback